Latest Articles
China Fangda Partners January 2019
Orphan Drugs & Rare Diseases: China
An intro to the legal situation for orphan drugs and rare diseases in China. Prepared in association with Fangda Partners, one of China’s most prestigious and well-regarded law firms. This is an extract from The Pharma Legal Handbook: China, which can be purchased here for GBP 119. 1. What is the definition of Rare Diseases…
Poland February 2021
Orphan Drugs & Rare Diseases: Poland
All legal aspects surrounding orphan drugs and rare diseases in the Polish pharma market. Prepared in association with DLA Piper, a leading law firm in Poland, this is an extract from The Pharma Legal Handbook: Poland, available to purchase here for GBP 119. 1. What is the definition of Rare Diseases in your country? There…
An intro to the legal situation for orphan drugs and rare diseases in Colombia. Prepared in association with Cavelier Abogados, a leading global law firm, this is an extract from The Pharma Legal Handbook: Colombia, available to purchase here for GBP 119. 1. What is the definition of Rare Diseases in your country? According to…
Peru Osterling Abogados February 2019
Orphan Drugs & Rare Diseases: Peru
Key legal info on orphan drugs & rare diseases in Peru. Prepared in association with Osterling Abogados, a leading global law firm, this is an extract from The Pharma Legal Handbook: Peru, available to purchase here for GBP 119. 1. What is the definition of Rare Diseases in your country? Rare Diseases are defined,…
Key legal info on orphan drugs & rare diseases in Swiss Pharma. Prepared in association with Wenger Plattner, a leading law firm in Switzerland, this is an extract from The Pharma Legal Handbook: Switzerland, available to purchase here for GBP 119. 1. What is the definition of Rare Diseases in your country? A disease is…
An intro to the legal situation for orphan drugs and rare diseases in Czech Republic. Prepared in association with PRK Partners, a leading law firm in Czech Republic, this is an extract from The Pharma Legal Handbook: Czech Republic, available to purchase here for GBP 119. 1. What is the definition of Rare Diseases in…
Vietnam February 2021
Orphan Drugs & Rare Diseases: Vietnam
Keen to learn more about orphan drugs & rare diseases in Vietnam? Read on! Prepared in association with Tilleke & Gibbins, a leading law firm in Vietnam, this is an extract from The Pharma Legal Handbook: Vietnam, available to purchase here for GBP 119. 1. What is the definition of Rare Diseases in your…
Argentina February 2021
Orphan Drugs & Rare Diseases: Argentina
Keen to learn more about orphan drugs & rare diseases in Argentina? Read on! Prepared in association with Marval, O’Farrell & Mairal, a leading global law firm, this is an extract from The Pharma Legal Handbook: Argentina, available to purchase here for GBP 119. 1. What is the definition of Rare Diseases in your country? According…
Orphan drugs & rare diseases in Croatia – a legal guide. Prepared in association with Danijel Pribanić, a leading global law firm, this is an extract from The Pharma Legal Handbook: Croatia, available to purchase here for GB 119. 1. What is the definition of Rare Diseases in your country? Simply put, an orphan…
The ins and outs of orphan drugs & rare diseases in Japan. Prepared in association with Nishimura & Asahi, a leading law firm in Japan, this is an extract from The Pharma Legal Handbook: Japan, available to purchase here for GBP 149. 1. What is the definition of Rare Diseases in your country? In Japan,…
